A Phase II Trial Evaluating 18F-Fluciclovine PET/CT in Multiple Myeloma
Latest Information Update: 15 Mar 2025
At a glance
- Drugs Fluciclovine 18F (Primary)
- Indications Multiple myeloma
- Focus Diagnostic use
- 15 Jul 2024 Planned number of patients changed from 55 to 60.
- 25 Mar 2024 Planned initiation date (estimated date of first participant enrollment) changed to 31 Mar 2024.
- 27 Feb 2024 Planned initiation date (estimated date of first participant enrollment) changed from 29 Feb 2024 to 4 Mar 2024.